(±)-Equol Estrogen/progestogen Receptor agonist

Cat.No.S6601

(±)-Equol, an isoflavandiol estrogen, is a metabolite of the soy isoflavones, daidzin and daidzein.
Jump to

Quality Control

Batch: Purity: 99.94%
99.94

Solubility

In vitro
Batch:

DMSO : 48 mg/mL (198.12 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 48 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 242.27 Formula

C15H14O3

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 94105-90-5 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-06-02)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07194590 RECRUITING
Chronic Kidney Disease (Stage 3-4); Vascular Function; Cognitive Functions; Cerebrovascular Function; Blood Pressure
University of Colorado, Denver
2026-02-19 PHASE2
NCT06128278 RECRUITING
Chronic Kidney Diseases; Vascular Function; Women
University of Colorado, Denver
2023-03-07 PHASE2
NCT05741060 ACTIVE_NOT_RECRUITING
Arterial Stiffness; White Matter Lesions; Cognitive Decline
Akira Sekikawa
2023-06-29 PHASE2
NCT07742501 COMPLETED
Cognition; Mood
University of Reading
2024-11-01
NCT07742514 COMPLETED
Cognition; Mood
University of Reading
2024-11-14
NCT03101085 COMPLETED
Alzheimer Disease
Russell Swerdlow
2017-05-05 PHASE1; PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map